Mepilex Border Ag Antimicrobial Foam Dressing 12.5 x 12.5 cm

Product Overview

Mepilex Border Ag is Mölnlycke's flagship antimicrobial silver foam dressing for clinically-infected or infection-risk wounds. The 12.5 x 12.5 cm bordered configuration delivers a self-adherent, all-in-one solution that eliminates the need for secondary fixation in most clinical contexts. The dressing combines Safetac® — the original soft-silicone wound contact layer — with a silver sulphate / activated-carbon foam core that releases ionic silver in response to wound exudate.

The five-layer construction comprises a Safetac silicone wound-contact layer, an absorbent polyurethane foam pad containing silver sulphate, a super-absorbent polyacrylate fibre retention layer, a non-woven distribution layer, and a vapour-permeable, bacterial- and viral-barrier polyurethane backing film. Independent in-vitro work has demonstrated >=99.9% reduction of MRSA, MSSA, Pseudomonas aeruginosa, Enterococcus faecalis (including VRE), and Candida albicans within 30 minutes of contact, with antimicrobial activity sustained for up to seven days.

Specifications

Clinical Indications

• Locally-infected, critically-colonised or at-risk acute and chronic wounds
• Diabetic foot ulcers (Wagner 1–3) and infected venous leg ulcers under compression
• Pressure ulcers Category II–IV at risk of bacterial bioburden
• Surgical wound dehiscence with suspected colonisation
• Partial-thickness burns and donor sites where infection control is required
• Step-down from systemic antibiotic therapy as part of a TIME / wound-bed-preparation strategy (EWMA 2019)

Frequently Asked Questions

Q: Why select an Ag (silver) dressing over a non-antimicrobial foam?
A: International Wound Infection Institute (IWII) 2022 consensus recommends topical antimicrobial agents — including ionic silver — as a structured 2-week therapeutic challenge for wounds with local infection (NERDS / STONEES criteria). A non-antimicrobial foam such as standard Mepilex Border is appropriate for clean granulating wounds.

Q: How long should silver therapy be continued?
A: Per IWII guidance and the Wounds International “Silver-2-Weeks” position, antimicrobial silver should be applied for a defined 2-week challenge with reassessment. Discontinue and step down to a non-antimicrobial foam if infection markers resolve; escalate if no improvement.

Q: Is Mepilex Border Ag MRI-safe?
A: Mepilex Border Ag contains silver sulphate, an ionic compound. Per Mölnlycke IFU and standard radiology practice, silver-containing dressings should be removed prior to MRI imaging to avoid local heating artefact, and a fresh dressing applied immediately afterwards.

Q: Can it be used in conjunction with negative-pressure wound therapy (NPWT)?
A: Mepilex Border Ag is not designed as an NPWT interface dressing. For NPWT cycles use Mölnlycke’s NPWT-specific portfolio (e.g., Avance system foams), and reserve Mepilex Border Ag for the post-NPWT phase or non-NPWT segments of the wound bed.

Q: How is Mepilex Border Ag procured for Singapore healthcare facilities?
A: EMIS — Essential Medical International Supplies (Singapore) — supplies the Mölnlycke wound-care range to public and private hospitals, polyclinics, community-care nursing services and aged-care providers. HSA-listed, with consignment, bulk and case-pack invoicing available.

References: Mölnlycke Mepilex Border Ag IFU; CE MDR 2017/745; FDA 510(k) Database; ISO 13485:2016; International Wound Infection Institute (IWII) Consensus 2022; Wounds International “Silver in Wound Care” position document; EWMA 2019 wound bed preparation guidance.